Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Type 3 ILCs in lung disease

  • Amanda Ardain
  • , James Zachary Porterfield
  • , Henrik N. Kløverpris
  • , Alasdair Leslie

Producción científica: Review article › revisión exhaustiva

64 Citas (Scopus)

Resumen

The lungs represent a complex immune setting, balancing external environmental signals with a poised immune response that must protect from infection, mediate tissue repair, and maintain lung function. Innate lymphoid cells (ILCs) play a central role in tissue repair and homeostasis, and mediate protective immunity in a variety of mucosal tissues, including the lung. All three ILC subsets are present in the airways of both mice and humans; and ILC2s shown to have pivotal roles in asthma, airway hyper-responsiveness, and parasitic worm infection. The involvement of ILC3s in respiratory diseases is less well-defined, but they are known to be critical in homeostasis, infection and inflammation at other mucosal barriers, such as the gut. Moreover, they are important players in the IL17/IL22 axis, which is key to lung health. In this review, we discuss the emerging role of ILC3s in the context of infectious and inflammatory lung diseases, with a focus on data from human subjects.

Idioma originalEnglish
Número de artículo92
PublicaciónFrontiers in Immunology
Volumen10
N.ºJAN
DOI
EstadoPublished - 2019

Nota bibliográfica

Publisher Copyright:
© 2019 Ardain, Porterfield, Kløverpris and Leslie. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Financiación

This work was supported by Wellcome Trust by AL Grant No. 210662/Z/18/Z; HK Grant No. 202485/Z/16/Z.

FinanciadoresNúmero del financiador
Wellcome Trust210662/Z/18/Z, 202485, 202485/Z/16/Z.
Wellcome Trust

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • Immunology and Allergy
    • Immunology

    Huella

    Profundice en los temas de investigación de 'Type 3 ILCs in lung disease'. En conjunto forman una huella única.

    Citar esto